A Study To Understand How Radiolabelled PF-04449913 Is Taken Up By The Body, Broken Down And Then Removed From The Body
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The study aims to understand, using radiolabelled PF-04449913, how this compound is modified
by the body once it is absorbed. The study also aims to understand how much of the compound
is broken down and how much leaves the body unchanged.